Emirates Oncology Society (EOS) shared on LinkedIn:
“Join EOS for Evolving Landscape in 1L HR+/ HER2- aBC Webinar
- Thursday, 5 November 2026, Virtual, 2 CME Hours
- 08:30 PM UAE | 04:30 PM UK | 11:30 PM New York | 05:30 PM Spain | 06:30 PM Cairo
- International Speaker: Adam M. Brusfsky
- Moderator: Dr. Hassan Jaafar
- Speakers: Dr. Fathi Azribi, Dr. Dina Hamza
- Panelists: Dr. Aref Chehal, Dr. Muhammad Farooq Latif, FRCP(Glasg), FRCP(Edin), FRCR, Dr. Dalia Elshorbagy, Dr. Amin Abyad
Join leading experts for an engaging scientific discussion on evolving treatment approaches and the latest evidence shaping first-line management of HR+/HER2-negative advanced breast cancer.
- Register Now
- Endorsed by: Emirates Oncology Society (EOS)
- Sponsored by: AstraZeneca”
The Evolving Landscape in 1L HR+/HER2- Advanced Breast Cancer Webinar, organized by the Emirates Oncology Society (EOS), brings together international and regional oncology specialists to discuss the latest developments in treating HR+/HER2-negative advanced breast cancer. The discussion focuses on first-line treatment options, emerging clinical evidence and new approaches to managing the disease.
The webinar features Prof. Adam M. Brusfsky as the international speaker, with Dr. Hassan Jaafar as moderator and several regional experts participating as speakers and panelists. Held virtually on 5 November 2026, the event offers two CME hours and is sponsored by AstraZeneca.
Read more articles about EOS on OncoDaily.
